Abstract
Osteoclasts degrade bone matrix proteins via the secretion of lysosomal enzymes. However, the precise mechanisms by which lysosomal components are transported and fused to the bone-apposed plasma membrane, termed ruffled border membrane, remain elusive. Here, we identified coronin 1A as a negative regulator of exocytotic release of cathepsin K, one of the most important bone-degrading enzymes in osteoclasts. The modulation of coronin 1A expression did not alter osteoclast differentiation and extracellular acidification, but strongly affected the secretion of cathepsin K and osteoclast bone-resorption activity, suggesting the coronin 1A-mediated regulation of lysosomal trafficking and protease exocytosis. Further analyses suggested that coronin 1A prevented the lipidation-mediated sorting of the autophagy-related protein LC3 to the ruffled border and attenuated lysosome–plasma membrane fusion. In this process, the interactions between coronin 1A and actin were crucial. Collectively, our findings indicate that coronin 1A is a pivotal component that regulates lysosomal fusion and the secretion pathway in osteoclast-lineage cells and may provide a novel therapeutic target for bone diseases.
Osteoclasts differentiate from cells of the monocyte/macrophage lineage by the fusion of precursor cells into multinucleated cells in response to macrophage colony-stimulating factor (M-CSF) and receptor activator of nuclear factor kappa-B ligand (RANKL)1,2. RANKL-induced activation of the nuclear factor kappa-B (NF-κB) and mitogen-activated protein kinase (MAPK) signalling pathways result in the increase in nuclear factor of activated T cells cytoplasmic 1 (NFATc1) and the expression of its target genes, including those encoding cathepsin K, ATPase H+ transporting V0 subunit d2 (Atp6v0d2) and tartrate-resistant acid phosphatase (TRAP)3,4. Osteoclasts resorb bones by attaching to the bone surface and forming a ruffled border, which is a part of the plasma membrane surrounded by an actin ring tightly adhered to the bone matrix; and by secreting lysosomal proteases such as cathepsin K from the ruffled border membranes into the acidic extracellular space5,6,7. In fact, delivery of lysosomal vesicles containing bone-degrading proteases to the ruffled border and the related exocytotic events are necessary for precisely controlled bone resorption8,9,10. Because an imbalance of bone homeostasis such as excessive or defective bone resorption causes various skeletal disorders11, there is a tremendous need for improved understanding of the mechanisms of bone resorption. Previous studies showed that the formation of a ruffled border and/or the transport of secretary lysosome requires synaptotagmin VII, Rab7, Rab27A and protein-kinase C (PKC) δ9,12,13,14. However, the detailed mechanisms of delivery or fusion of lysosomal vesicles to the ruffled border membrane in osteoclasts remain poorly understood.
Similarly to the lysosomal fusion with ruffled border membranes in osteoclasts, autophagy is a system that requires dynamic membrane trafficking and fusion with the lysosome. Autophagy, which is a process of self-degradation of cellular components via lysosomal fusion, contributes to the adaptation to a nutritionally deficient state and maintenance of cellular homeostasis through removing damaged organelles, invasive pathogens and aggregated proteins15,16,17. However, recent studies suggested that autophagy also participates in osteoclast differentiation and function18,19. Deletion of autophagy-related (Atg) 5 or Atg 7 in cells of the monocyte/macrophage lineage impairs the proper assembly of the ruffled border and reduces localization of the autophagic protein LC3 within actin rings, resulting in lower resorption activity in vitro and slightly increased bone volume in vivo20,21. These reports suggest that autophagic proteins are involved in proper osteoclast formation and osteoclastic bone resorption.
Coronin 1A is a member of the coronin family of actin-associated proteins and is highly expressed in hematopoietic cells22,23,24. This protein contains 461 amino acids and is comprised of the following three functional domains: an amino-terminal tryptophan-aspartic acid (WD) repeat-containing region followed by a unique region and a carboxy-terminal coiled-coil domain22,23. Because coronin 1A interacts with actin, it has been assumed to be involved in cytoskeletal regulation, however, coronin 1A-deficient macrophages exhibit intact cell motility and phagocytosis22,23. On the other hand, coronin 1A has been identified as an inhibitor of the lysosomal degradation pathway by preventing the fusion of endosomes/phagosomes with lysosomes25,26,27,28. Furthermore, coronin 1A is important for calcium mobilization and calcineurin activation25,27,29. Of note, both calcium–calcineurin signalling and lysosomal fusion are necessary for osteoclast differentiation and function, respectively; the calcium–calcineurin signalling-induced activation of NFATc1 is essential for osteoclasts differentiation, and the fusion of lysosomal vesicles to ruffled border plasma membrane is important for the release of bone-degrading enzymes that function in osteoclastic bone resorption. However, the role of coronin 1A in osteoclasts is unknown. In the present study, we investigated the involvement of coronin 1A in osteoclast differentiation and function and revealed that the modulation of coronin 1A expression levels alteres the activity of osteoclastic bone resorption without affecting osteoclastogenesis and that coronin 1A inhibits lysosome fusion to plasma membrane of the ruffled border and cathepsin K secretion.
Results
Expression patterns of coronin 1A and its localization during osteoclast differentiation
We hypothesized that the actin-binding protein coronin 1A might play a crucial role in osteoclast differentiation and/or function. Therefore, we first analysed the expression and localization of coronin 1A during osteoclast differentiation. Coronin 1A was highly expressed in osteoclast precursor cells (bone marrow macrophages; BMMs) and was decreased during osteoclastogenesis in both mRNA and protein levels (Fig. 1a,b). Coronin 1A expression was decreased in BMMs from 24 h after RANKL stimulation and continued to decrease until 48 h. Coronin was first identified in Dictyostelium and was characterized as an actin-binding protein. Consistent with the previous reports22,24,30, coronin 1A was distributed near the plasma membrane and co-localized to F-actin (Fig. 1c). Of note, coronin 1A was detected in osteoclast precursor cells (Fig. 1c: small cells), but to a lesser extent in mature osteoclasts (Fig. 1c: multinucleated cells [MNCs, >3 nuclei]), confirming that coronin 1A is reduced during osteoclastogenesis.
Role of coronin 1A in RANKL-dependent osteoclastogenesis
We next investigated whether coronin 1A is required for RANKL-induced osteoclastogenesis. Primary BMMs infected with empty lentiviral vector or coronin 1A-expressing lentivirus were cultured with M-CSF and RANKL (Supplementary Fig. 1a,b), following which they were stained for TRAP, a marker of osteoclasts. Despite the importance of coronin 1A in calcium–calcineurin signalling25,27,29, which had been shown to be important for osteoclastogenic NFATc1 autoamplification3,4,31, the enforced coronin 1A expression did not affect RANKL-induced osteoclast differentiation (Fig. 2a,b) and NFATc1 induction (Fig. 2c) as well as precursor cell proliferation or survival (Supplementary Fig. 2a,b). Similar to the effects of overexpression of coronin 1A, its knockdown in BMMs did not affect osteoclastogenesis (Fig. 2d–f, Supplementary Fig. 1c) and precursor cell proliferation or survival (Supplementary Fig. 2c,d). Subsequently, we examined the role of coronin 1A in RANKL-dependent signalling pathways, including extracellular signal-regulated kinase (ERK), p38, c-Jun N-terminal kinases (JNK), NF-κB and v-akt murine thymoma viral oncogene (AKT), which are activated via the RANKL-TNF receptor-associated factor 6 (TRAF6)-dependent pathway32. As shown in Supplementary Fig. 3a and b, neither coronin 1A overexpression nor knockdown affected RANKL-dependent NF-κB, MAPK and AKT activation. In addition, mRNA expression levels of the osteoclastogenic markers Nfatc1, Dcstamp, ATPase H+ transporting V0 subunit d2 (Atp6v0d2), Acp5 and Ctsk were not significantly affected by coronin 1A overexpression or its knockdown (Fig. 2c,f). These results indicated that the role of coronin 1A in osteoclast differentiation is minute.
Osteoclastic bone resorption activity regulated by coronin 1A
Bone resorption requires lysosomal trafficking to and fusion with ruffled border8,9,10. Since coronin 1A has been identified to inhibit lysosomal fusion25,26,27,28, we assessed whether coronin 1A is involved in osteoclastic bone resorption activity. When osteoclasts were cultured on the bone biomimetic synthetic surface, resorption pits formed by coronin 1A-overexpressing osteoclasts were significantly smaller than those formed by control cells (Fig. 3a,b). Previous studies showed that cathepsin K is a key player in bone resorption via degradation of bone-matrix proteins, type I and type II collagen33,34,35,36. Thus, we focused on cathepsin K and assessed the amount of cathepsin K in whole cell lysates and culture supernatants by immunoblotting. We found that the amount of cathepsin K in the culture supernatants of coronin 1A-overexpressing osteoclasts was significantly smaller than that of control cells, whereas the total expression levels of cathepsin K in whole cell lysates did not differ between coronin 1A-overexpressing cells and control cells (Fig. 3c). In line with these results, the bone resorption area and the amount of cathepsin K in the culture supernatants tended to increase in osteoclasts transfected with coronin 1A specific small interfering (si)RNA, without any changes in the expression of cathepsin K (Fig. 3d–f), suggesting that coronin 1A inhibits cathepsin K secretion from osteoclasts. Although cytokines are also contained in small secretary vesicles and are transported to the plasma membrane and released out into the extracellular space37, the secretion of proinflammatory cytokines, such as tumor necrosis factor (TNF), interleukin 6 (IL-6) and IL-12/IL–23p40 from BMMs was not affected by coronin 1A overexpression or its knockdown (Supplementary Fig. 4a,b). The extracellular acidification of osteoclast resorption lacunae, which is mediated by vacuolar H+ -ATPases (V-ATPases), is a prerequisite for efficient degradation of bone matrix proteins by cathepsin K10,38,39. Thus, we investigated whether coronin 1A is involved in the extracellular acidification of osteoclasts. Using Acridine orange staining assay, which has been widely used to reveal the extracellular acidification and/or proton-pump activity in osteoclasts40,41,42,43, we found that the extracellular acidification was not affected by the coronin 1A-overexpression or -knockdown compared with control cells (Supplementary Fig. 5a,b), suggesting that coronin 1A regulation of the osteoclast proton secretion is not likely. These results together suggested that coronin 1A plays an important and specific role in the secretion of lysosomal enzymes such as cathepsin K but not in the secretion of cytokines and osteoclast extracellular acidification.
Coronin 1A inhibits the localization of cathepsin K at ruffled border
We then focused on the influence of coronin 1A overexpression on spatiotemporal regulation of cathepsin K. We first investigated the actin-ring formation during osteoclast differentiation. Coronin 1A-overexpressing osteoclasts normally formed actin rings in response to RANKL (Fig. 3g,h), suggesting that cytoskeleton organization and the signals that activate this process are intact. However, the amount of cathepsin K localized within actin rings was greatly reduced by coronin 1A overexpression (Fig. 3g,i), indicating that coronin 1A prevents the sorting and/or fusion of cathepsin K-containing lysosomes to ruffled border membrane surrounded by actin rings. To obtain a more direct evidence of the regulatory role of coronin 1A in the fusion of lysosomes with the plasma membrane of ruffled border, we employed widely used LAMP1 (a lysosome marker) staining to assess the lysosomal fusion and found that coronin 1A overexpression impaired RANKL-induced localization of LAMP1 within osteoclast actin rings, which normally occurs after the lysosomal fusion to ruffled border membrane (Supplementary Fig. 6).
Coronin 1A inhibits LC3-I-to-II conversion and LC3 localization at ruffled border
Next, we attempted to clarify which mechanisms underlie the coronin 1A suppression of cathepsin K secretion. The previous study indicated that autophagic component LC3, one of eight mammalian Atg8 family of proteins, is converted from its cytosolic LC3-I form into LC3-II, which is a C-terminally phosphatidylethanolamine-conjugated form; and this post-translational modification process, called lipidation, is essential for both LC3 localization at ruffled border and lysosomal secretion from ruffled border21. Therefore, we quantified the production of LC3-II and examined LC3 localization in osteoclast-lineage cells using immunoblotting and confocal microscopy, respectively. LC3-II levels in osteoclasts were decreased by coronin 1A overexpression and were increased by the coronin 1A knockdown (Fig. 4a,b), suggesting the importance of coronin 1A for LC3 lipidation in osteoclasts. Moreover, enforced coronin 1A expression inhibited the localization of LC3 within actin ring (Fig. 4c,d). These results indicate that coronin 1A regulates LC3 lipidation and its localization at the osteoclast ruffled border.
As previously reported, small guanosin-5′-triphosphatase (GTPases) Rab7 and Rab27a are necessary for ruffled border formation and/or lysosomal secretion in osteoclasts12,13. Furthermore, the localization of Rab7 and LC3 are abnormal, and cathepsin K secretion is significantly decreased in Atg5-deficient osteoclasts21. Here, we asked whether coronin 1A overexpression could affect Rab7 or Rab27a in osteoclasts. The expression levels of Rab7 and Rab27a were not affected by coronin 1A overexpression (Supplementary Fig. 7a). Rab7 was observed principally at ruffled border in coronin 1A-overexpressing osteoclasts, and the co-localization with F-actin was evident both in coronin 1A-overexpressing and control osteoclasts (Supplementary Fig. 7b). In addition, Rab27a localization at cytoplasm was not also changed by coronin 1A overexpression (Supplementary Fig. 7b). These results indicated that coronin 1A specifically regulates LC3 lipidation and localization at ruffled border, but not Rab7 and Rab27a at least in osteoclasts.
Coronin 1A regulates osteoclastic bone resorption activity via the actin-related mechanism(s)
Coronin 1A has been known to interact with cytoskeleton24,30. Therefore, we hypothesized that coronin 1A regulates LC3 lipidation and localization through actin-related modulation. We first constructed a mutant of coronin 1A (with an R29D mutation) that is devoid of actin-binding ability44,45 and then examined its effect on osteoclastogenesis and bone resorption. Coronin 1A overexpression by lentivirus (Supplementary Fig. 8), regardless of the R29D mutation, did not affect osteoclastogenesis (Fig. 5a,b). However, interestingly, the R29D mutation in coronin 1A reversed the inhibitory effect of coronin 1A overexpression on osteoclastic bone resorption activity (Fig. 5c,d). Of note, suppression of LC3 lipidation and cathepsin K secretion by coronin 1A overexpression were also abolished with the actin-binding deficient R29D mutant (Fig. 5e,f ). These results strongly indicated that the interaction between coronin 1A and actin is crucial for coronin 1A-mediated suppression of bone resorption.
Effect of enforced expression coronin 1A on lipopolysaccharide (LPS)-induced bone resorption in vivo
Finally, we assessed whether enforced expression of coronin 1A would affect the severity of LPS-induced bone resorption in a mouse model. Mice were injected with LPS and adenovirus expressing LacZ (Ad LacZ: control) or coronin 1A (Ad coronin 1A), and we found that although the number of TRAP-positive cells on the bone surface was only slightly affected (Fig. 6a,b), Ad coronin 1A-injected mice showed less susceptibility to LPS-induced bone loss compared to Ad LacZ-injected mice; i.e., histological analysis (Fig. 6c), micro computed tomography (Fig. 6d) and the levels of serum CTx-I (collagen type 1 cross-linked C-telopeptide: a marker for bone resorption) (Fig. 6e) showed a significant decrease in bone resorption in the Ad coronin 1A-injected mice, suggesting that the coronin 1A-mediated machinery also operates in vivo and plays a crucial role in regulating bone resorption.
Discussion
In the context of osteoclastic secretion of bone-degrading enzymes, the precise mechanism of the trafficking and fusion of lysosomal cargo to the ruffled border membranes remains poorly understood. In the present study, we revealed that coronin 1A is a negative regulator of cathepsin K secretion in osteoclast-lineage cells. Interestingly, coronin 1A prevented LC3 lipidation and LC3 localization to the ruffled border membranes, and the R29D mutation in coronin 1A reversed the inhibitory effects, indicating that coronin 1A attenuates the lipidation-mediated LC3 sorting through its binding capacity to actin.
Autophagy-related proteins have been shown to be responsible for lysosomal secretion in osteoclasts and melanocytes21,46,47. Actually, the autophagy-related proteins Atg5, Atg7, Atg4B and LC3, a member of the Atg8 family proteins, have been shown to be important in osteoclastic bone resorption, and LC3 lipidation and LC3 localization at ruffled border membrane were shown to be critical for efficient cathepsin K secretion in osteoclasts21. In addition, the deletion of coronin 1A was reported to enhance the recruitment of LC3 to phagosomes in macrophages26. Moreover, the small GTPase Rab7 has been identified as an essential component for both autophagosome fusion to lysosomes in variable cells and ruffled border formation in osteoclasts12,48,49.These reports collectively suggested that the autophagic pathway and the lysosomal secretion of bone-degrading enzymes in osteoclasts might share common molecular mechanisms, and it is likely that coronin 1A inhibits cathepsin K secretion by suppressing the cellular autophagic machinery. However, notably, knocking out the Map1lc3b gene (encoding LC3-β, a representative member of MAP1LC3/LC3 protein family in mammals21,50) did not affect osteoclast phenotype21, perhaps reflecting functional redundancy among Atg8 family members, such as GABARAP and GATE-1621,50,51. In accordance with these reports, osteoclastogenesis, cathepsin K-secretion and bone resorption activity of osteoclasts were not significantly changed by siRNA-mediated knockdown of LC3-β (Supplementary Fig. 9a–c). Future studies are needed to evaluate the significance of LC3 pathway and interplay among the Atg8 family proteins. During autophagosome formation, Atg12 is conjugated to Atg5 irreversibly, and the Atg12–Atg5 conjugate contributes to LC3 lipidation with its E3 ligase-like function52,53,54. Atg16L further forms a complex with the Atg12–Atg5 conjugate and facilitates LC3 lipidation52,53,54. Therefore, it may be possible that actin filament-bound coronin 1A attenuates the function of Atg12–Atg5 complex and/or Atg16L by yet unknown mechanisms.
Coronin 1A was also identified as an F-actin stabilizer against depolymerization55. Moreover, F-actin stabilization on phogosomal membrane by coronin 1A is required to block phagosome–lysosome fusion25,56. Therefore, it is possible that coronin 1A not only prevents LC3 lipidation and localization via the actin-related mechanism, but also protects plasma membranes (other than ruffled border membranes) from fusing with lysosomal vesicles through stabilizing actin cytoskeleton to prevent aberrant release of lysosomal enzymes. Further studies are required to prove this hypothesis.
It is noteworthy that previous studies have shown that coronin 1A plays a role in calcium mobilization as well as phagosome/endosome fusion to lysosomes25,27. Although calcium mobilization is a prerequisite for the calcium–calcineurin–NFATc1 signalling, the modulation of coronin 1A expression did not affect the NFATc1 activation and osteoclast differentiation. This fact suggests that coronin 1A-independent calcium–calcineurin signalling operates in osteoclastogenesis or that the existence of other coronin family proteins simply masks the gain- and loss-of-function phenotype(s) of coronin 1A mutant cells in osteoclastogenesis. In fact, there are seven coronin genes in mammals. Although coronin family members share a common structure, i.e. WD repeats and a carboxy-terminal coiled-coil domain, functional redundancy among coronin family proteins has not been fully characterized. Indeed, although five coronin members, coronin 1A, 1B, 1C, 2A and 7, are expressed in macrophages, only coronin 1A has been identified as a regulator of phagosomal membrane fusion with lysosomes25,57. This may explain the strong phenotype in coronin 1A mutant cells concerning osteoclast function but not osteoclastogenesis. To completely elucidate the functional redundancy among coronin family proteins in osteoclast differentiation and function, further studies will be required.
We showed that coronin 1A knockdown or overexpression strongly affected bone resorption. Nevertheless, to date, an abnormal bone phenotype in coronin 1A-deficient mice has never been reported. The previous study showed that autophagic protein Atg5-deficient osteoclasts exhibit a remarkable reduction in osteoclastic bone resorption activity in vitro; but Atg5-deficient mice only showed a minimal increase in bone mass21. However, Atg5-deficient mice were protected from ovariectomy- or ageing-induced bone loss21, suggesting that a defect in autophagic machinery may cause a strong defect in osteoclasts in vitro; however, for unknown reasons, bone remodeling appears normal in vivo unless osteoclasts are activated by a relevant ‘challenge’. Accordingly, bone mass in coronin 1A-deficient mice also might be affected by pathological challenges.
In the present study, we showed that RANKL stimulation downregulated coronin 1A expression (Fig. 1). The coronin 1A promoter region contains a binding site for the Maf family of transcription factors, as detected by using the MATCH program and the TRANScription FACtor (TRANSFAC) database. MafB, one of the Maf family of transcription factors, is expressed in monocytes and macrophages and has been reported to negatively regulates RANKL-induced osteoclastogenesis58; the expression of MafB itself is downregulated by RANKL stimulation59. These data may imply the possible relationship between RANKL-induced suppression of MafB expression and the downregulation of coronin 1A during osteoclastogenesis.
Regarding the role of coronin 1A in osteoclast precursor cells, i.e., in monocyte/macrophage-lineage cells, it has been shown that the inflammatory stimulation-induced coronin 1A phosphorylation triggers cellular switching from phagocytosis to micropinocytosis, which enables efficient uptake and degradation of large amounts of infectious materials60,61, suggesting that coronin 1A is important for host defense against infection. How about the role of coronin 1A in premature osteoclasts then? Premature osteoclasts actually express a large quantity of cathpsin K in cells, however, they would not considerably secrete it until they reach a later stage of maturation and firmly stick to the bones. Given the high expression of coronin 1A in macrophages and premature osteoclasts, it raises the intriguing possibility that coronin 1A operates mainly in those cells to tightly regulate lysosomal secretion of vital enzymes such as cathepsins. However, further studies are required to address this point.
In conclusion, we have demonstrated that coronin 1A and its binding to actin play an important role, possibly in concert with autophagic machinery, in regulating cathepsin K secretion in osteoclast-lineage cells. The present study thus provides a novel therapeutic target for bone diseases such as osteoporosis and rheumatoid arthritis.
Materials and Methods
Mice
C57BL/6 J mice were purchased from CLEA Japan (Japan). All experimental protocols were approved by the Animal Research Committee in Kyoto University, and this study was carried out in accordance with the Regulation on Animal Experimentation in Kyoto University.
In vitro osteoclastogenesis
Bone marrow cells derived from mice were seeded (2.5 × 105 cells per well in a 24 well plate) and cultured in α-minimum essential medium (α-MEM) with 10% fetal bovine serum (FBS) containing 10 ng/mL recombinant M-CSF (PeproTech). After two days, adherent cells were used as BMMs. These osteoclast progenitor cells were further cultured in the presence of 50 ng/mL recombinant RANKL (PeproTech) and 10 ng/mL recombinant M-CSF to generate mature osteoclasts for 48–72 h. The presence of osteoclasts was confirmed by TRAP staining. TRAP-positive multinuclear cells (more than three nuclei) were counted.
RNA interference
The stealth small interfering RNAs (siRNAs) targeting mouse coronin 1A and LC3-β were designed and synthesized by Invitrogen. The siRNA sequences are as follows: si-coronin 1A: 5′-UUGUCUACUCGUCCAGUCUUGCCUA-3′, si-coronin 1A: 5′-UGUAGAUUGUGUCCGGGUGCACAUC-3′ and si-LC3-β: 5′-CAGCUCAAUGCUAACCAAGCCUUCU-3′, si-luciferase (negative control): 5′-ACAUCACGUACGCGGAAUACUUCGA-3′. BMMs were transfected with siRNAs (40 nmol) with Lipofectamine RNAiMAX reagent (Invitrogen), according to the manufacturer’s protocol. After 48 h, the BMMs were cultured with M-CSF and RANKL for osteoclast generation or protein analysis.
Lentiviral-mediated gene transfer
The recombinant lentivirus vector that carried either wild-type mouse coronin 1A (Coronin 1AA [wt]) or actin-binding defective mouse coronin 1A (Arg 29 to Asp mutant, Coronin 1A [R29D]) gene was constructed. To generate lentiviruses, 293 T cells were transfected with the lentivirus vector (CSII-CMV-MCS-IRES2-Venus), in combination with the packaging plasmid (pCAG-HIVgp) and the VSV-G- and Rev-expressing plasmid (pCMV-VSV-G-RSV-Rev) by calcium phosphate coprecipitation and incubated for 12 h. After removing the medium, cells were cultured in Dulbecco’s Modified Eagle Medium (DMEM) containing 10 μM forskolin for 48 h, and virus supernatants were collected. BMMs were transduced with virus supernatant for 24 h in the presence of 10 μg/mL polybrene (Sigma). The BMMs were cultured with M-CSF and RANKL for osteoclast generation.
Real-time PCR
Total RNAs from the cultured cells were extracted with the RNeasy kit (Qiagen). First-strand cDNA was then produced from total RNA using Reverse Transcriptase SuperScript III (Invitrogen). Coro1a, Nfatc1, Dcstamp, Atp6v0d2, Acp5 and Ctsk transcripts were quantified on a LightCycler 480 (Roche) using SYBR green. These transcripts were normalized to glyceraldehyde-3-phosphate dehydrogenase (Gapdh) transcripts. Primers for mouse Coro1a (forward 5′-TTCCCTCAAGGATGGCTACGT-3′ and reverse 5′-CTCCGGCCTAGCCATGTGAT-3′), mouse Nfatcl (forward 5′-GGTAACTCTGTCTTTCTAACCTTAAGCTC-3′ and reverse 5′-GTGATGACCCCAGCATGCACCAGTCACAG-3′), mouse Ctsk (forward 5′-GCCAGGATGAAAGTTGTATG-3′ and reverse 5′-CAGGCGTTGTTCTTATTCC-3′), mouse Dcstamp (forward 5′-TGTATCGGCTCATCTCCTCCAT-3′ and reverse 5′-GACTCCTTGGGTTCCTTGCTT-3′), mouse Atp6v0d2 (forward 5′-GAAGCTGTCAACATTGCAGA-3′ and reverse 5′-TCACCGTGATCCTTGCAGAAT-3′), mouse Acp5 (forward 5′-ACTTCCCCAGCCCTTACTACCG-3′ and reverse 5′-TCAGCACATAGCCCACACCG-3′), mouse Gapdh (forward 5′-TCACCATCTTCCAGGAGCGA-3′ and reverse 5′-GCATTGCTGACAATCTTGAGTGAG-3′).
Immunoblot analysis
The cells were lysed with CelLytic M solution (Sigma-Aldrich). After centrifugation, the supernatant was collected, mixed with SDS sample buffer, and boiled for 5 min at 98 °C. The sample was applied to SuperSep Ace gel (Wako), separated by a standard SDS-PAGE method, and then transferred onto polyvinylidene fluoride membranes, blocked with 5% skim milk and incubated at 4 °C overnight with anti-Akt, anti-p-Akt (S473) anti-p38, anti-p-p38 (T180/Y182), anti-ERK, anti-p-ERK (T202/Y204), anti-JNK, anti-p-JNK (T183/Y185) (dilution 1:3,000; Cell Signaling Technology), anti-cathepsin K (dilution 1:1,000; Santa Cruz), anti-coronin1A, anti-rab7 (dilution 1:3,000; Abcam), anti-LC3 (HRP conjugate) (dilution 1:2,000; MBL), anti-rab27a (dilution 1:3,000; R&D) and anti-β-actin (HRP conjugate) (dilution 1:2,000; Cell Signaling Technology). The membranes were washed and incubated with horseradish peroxidase-conjugated secondary antibodies. Chemiluminescence was detected using ImmunoStar LD (Wako), and images were captured by using LAS-4000 mini (Fujifilm) or Amersham Imager 600 (GE Healthcare).
Assesment of osteoclastic bone resorption activity
BMMs were cultured on the bone biomimetic synthetic surface plate and differentiation to osteoclasts was induced. The cells were removed from the plates, and bone pits generated by osteoclasts were stained and visualized by von Kossa staining. After washing the wells, pits were imaged by microscopy (Evos; Thermo Fisher Scientific). The pits were analysed using MetaMorph software.
Immunofluorescence and microscopy
BMMs were cultured on glass or dentine slides and induced to differentiate into osteoclasts. Osteoclasts were fixed with 4% paraformaldehyde for 15 min then washed three times with phosphate buffered saline with Tween 20 (PBST). Cells were permeabilized in 0.1% Triton-X for 10 min and blocked for 1 h in PBST containing 2.5% bovine serum albumin (BSA) and 10% normal goat serum. Primary antibody diluted in Can Get Signal immunostain solution A (Toyobo) was added for 12 h at 4 °C, followed by 1 h incubation with secondary antibody together with phalloidin-647 (Abcam) and DAPI. The following antibodies were used: anti-coronin 1A (Abcam), anti-cathepsin K (Abcam), anti-LAMP1 (Cell Signaling Technology, Biolegend), anti-LC3 (MBL), anti-rab7 (Abcam), anti-rab27a (R&D), anti-mouse Alexa Fluor 488 and anti-rabbit Alexa Fluor 594 (both from Molecular Probes). Slides were imaged on LSM 710 (Zeiss) and analysed using MetaMorph software.
Acridine orange staining assay
The acidification activity was measured with Acridine orange staining assay according to previously described methods40. Osteoclasts were incubated in α-MEM with 10% FBS containing 5 μg/mL Acridine orange (Dojindo) for 15 min at 37 °C, then washed three times with PBS. The cells were incubated in fresh medium without Acridine orange for 10 min at 37 °C and observed by confocal microscope (LSM 710 [Zeiss]) with an appropriate filter set (excitation: 450- to 490-nm band-pass filter and emission: 515- to 565-nm band-pass filter or 600-nm long-pass filter). Images were analysed by using MetaMorph software.
LPS-induced bone resorption model
The recombinant adenovirus vector (pAdenoX-ZsGreen1) that carried mouse coronin 1A was constructed. To generate recombinant adenoviruses, Adeno-X 293 cells were transfected with the PacI-digested adenovirus by using Adeno-X™ Adenoviral System 3 (Clontech Laboratories) according to the manufacturer’s instructions. In total, 1 × 107 infection forming units (IFU) of virus diluted in 50 μL of PBS were injected onto the calvariae four times at one day intervals. Mice were administered with a local calvarial injection of LPS at 1.5 mg/kg body weight three times at two days intervals. Seven days after the first injection, the calvariae were collected and fixed in 4% paraformaldehyde and analysed histologically. The number of TRAP-positive cells per millimetre of calvarial bone surface was counted. The eroded surface per bone surface (ES/BS, %) was analysed by using MetaMorph software.
Micro-computed tomography analysis
Calvarial bones of the mice injected with adenovirus expressing LacZ or coronin 1A were analysed using ScanXmate-A100S Scanner (ComScanTechno, Yokohama, Japan) as described previously62. Three-dimensional microstructure images were reconstituted and the void volume on the surface of the calvarial bones was calculated by TRI/3D-BON software (RATOC System Engineering, Tokyo, Japan).
Statistical analysis
Data were presented as means ± standard error of the mean (SEM) and compared using the Student’s t-test or one-way analysis of variance (ANOVA) plus post hoc multiple comparisons using the Dunnett test. A value of P < 0.05 was considered significant.
Additional Information
How to cite this article: Ohmae, S. et al. Actin-binding protein coronin 1A controls osteoclastic bone resorption by regulating lysosomal secretion of cathepsin K. Sci. Rep. 7, 41710; doi: 10.1038/srep41710 (2017).
Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Material
Acknowledgments
We thank Drs S. Narumiya, M. Matsuda and T. Watanabe for their invaluable support, and S. Ito, K Nishikawa, K. Sato, T. Tsuji, T. Oku and the members of the AK project for discussion. This work was supported in part by the Special Coordination Funds for Promoting Science and Technology of the Japanese Government and in part by Astellas Pharma Inc. in the Formation of Innovation Center for Fusion of Advanced Technologies Program. This work was also supported by research grants from the Japanese Ministry of Health, Labour and Welfare (M. Asagiri, K.I.); a Grant-in-Aid for Young Scientists (24689056), a Grant-in-Aid for Challenging Exploratory Research (24659822) and a Grant-in-Aid for Scientific Research (16K10900) from Japan Society for the Promotion of Science; and a grant from the Kanae Foundation for the Promotion of Medical Science (M. Asagiri).
Footnotes
S.O., T.F. and M. Asagiri were partly employed by the Coordination Fund from the Japan Science and Technology Agency and Astellas Pharma Inc.; and T.F. and M. Asagiri received research grants from this fund. K.I. is employed by the Coordination Fund from Kyoto University and Chugai Pharmaceutical Co., Ltd.; and receive research grants from this fund. The authors have no additional conflict of interests.
Author Contributions S.O. designed the project and performed most experiments and analysed the data. N.N., M. Toyomoto, M. Takeiri, H.F., K.T. and M.K. assisted with the experiments and provided advice on project planning and data interpretation. M.S. contributed to the micro-computed tomography data analysis. K.I., T.F., N.T., M. Aoyama and Y.I. provided critical collaborative suggestions to support this study. S.O., M. Toyomoto and M.H. planned and conducted the animal experiments. M. Asagiri supervised the study. S.O. and M. Asagiri wrote the manuscript.
References
- Suda T. et al. Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr Rev 20, 345–357 (1999). [DOI] [PubMed] [Google Scholar]
- Boyle W. J., Simonet W. S. & Lacey D. L. Osteoclast differentiation and activation. Nature 423, 337–342 (2003). [DOI] [PubMed] [Google Scholar]
- Asagiri M. et al. Autoamplification of NFATc1 expression determines its essential role in bone homeostasis. J Exp Med 202, 1261–1269 (2005). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Asagiri M. & Takayanagi H. The molecular understanding of osteoclast differentiation. Bone 40, 251–264 (2007). [DOI] [PubMed] [Google Scholar]
- Baron R. et al. Polarized secretion of lysosomal enzymes: co-distribution of cation-independent mannose-6-phosphate receptors and lysosomal enzymes along the osteoclast exocytic pathway. J Cell Biol 106, 1863–1872 (1988). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Vaananen H. K., Zhao H., Mulari M. & Halleen J. M. The cell biology of osteoclast function. J Cell Sci 113 (Pt 3), 377–381 (2000). [DOI] [PubMed] [Google Scholar]
- Saftig P. et al. Functions of cathepsin K in bone resorption. Lessons from cathepsin K deficient mice. Adv Exp Med Biol 477, 293–303 (2000). [DOI] [PubMed] [Google Scholar]
- Yang D. Q. et al. V-ATPase subunit ATP6AP1 (Ac45) regulates osteoclast differentiation, extracellular acidification, lysosomal trafficking, and protease exocytosis in osteoclast-mediated bone resorption. J Bone Miner Res 27, 1695–1707 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zhao H. et al. Synaptotagmin VII regulates bone remodeling by modulating osteoclast and osteoblast secretion. Dev Cell 14, 914–925 (2008). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Stenbeck G. Formation and function of the ruffled border in osteoclasts. Semin Cell Dev Biol 13, 285–292 (2002). [DOI] [PubMed] [Google Scholar]
- Teitelbaum S. L. & Ross F. P. Genetic regulation of osteoclast development and function. Nat Rev Genet 4, 638–649 (2003). [DOI] [PubMed] [Google Scholar]
- Zhao H., Laitala-Leinonen T., Parikka V. & Vaananen H. K. Downregulation of small GTPase Rab7 impairs osteoclast polarization and bone resorption. J Biol Chem 276, 39295–39302 (2001). [DOI] [PubMed] [Google Scholar]
- Shimada-Sugawara M. et al. Rab27A regulates transport of cell surface receptors modulating multinucleation and lysosome-related organelles in osteoclasts. Sci Rep 5, 9620 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cremasco V. et al. Protein kinase C-delta deficiency perturbs bone homeostasis by selective uncoupling of cathepsin K secretion and ruffled border formation in osteoclasts. J Bone Miner Res 27, 2452–2463 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Klionsky D. J. Autophagy: from phenomenology to molecular understanding in less than a decade. Nat Rev Mol Cell Biol 8, 931–937 (2007). [DOI] [PubMed] [Google Scholar]
- Wong A. S., Cheung Z. H. & Ip N. Y. Molecular machinery of macroautophagy and its deregulation in diseases. Biochim Biophys Acta 1812, 1490–1497 (2011). [DOI] [PubMed] [Google Scholar]
- Mizushima N. & Komatsu M. Autophagy: renovation of cells and tissues. Cell 147, 728–741 (2011). [DOI] [PubMed] [Google Scholar]
- Hocking L. J., Whitehouse C. & Helfrich M. H. Autophagy: a new player in skeletal maintenance? J Bone Miner Res 27, 1439–1447 (2012). [DOI] [PubMed] [Google Scholar]
- Helfrich M. H. & Hocking L. J. Genetics and aetiology of Pagetic disorders of bone. Arch Biochem Biophys 473, 172–182 (2008). [DOI] [PubMed] [Google Scholar]
- Teitelbaum S. L. & Zou W. The osteoclast cytoskeleton: How does it work? IBMS BoneKEy 8, 74–83 (2011). [Google Scholar]
- DeSelm C. J. et al. Autophagy proteins regulate the secretory component of osteoclastic bone resorption. Dev Cell 21, 966–974 (2011). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Pieters J., Muller P. & Jayachandran R. On guard: coronin proteins in innate and adaptive immunity. Nat Rev Immunol 13, 510–518 (2013). [DOI] [PubMed] [Google Scholar]
- Jayachandran R. & Pieters J. Regulation of immune cell homeostasis and function by coronin 1. Int Immunopharmacol 28, 825–828 (2015). [DOI] [PubMed] [Google Scholar]
- Gatfield J., Albrecht I., Zanolari B., Steinmetz M. O. & Pieters J. Association of the leukocyte plasma membrane with the actin cytoskeleton through coiled coil-mediated trimeric coronin 1 molecules. Mol Biol Cell 16, 2786–2798 (2005). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Jayachandran R. et al. Survival of mycobacteria in macrophages is mediated by coronin 1-dependent activation of calcineurin. Cell 130, 37–50 (2007). [DOI] [PubMed] [Google Scholar]
- Seto S., Tsujimura K. & Koide Y. Coronin-1a inhibits autophagosome formation around Mycobacterium tuberculosis-containing phagosomes and assists mycobacterial survival in macrophages. Cell Microbiol 14, 710–727 (2012). [DOI] [PubMed] [Google Scholar]
- Suo D. et al. Coronin-1 is a neurotrophin endosomal effector that is required for developmental competition for survival. Nat Neurosci 17, 36–45 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Foger N. et al. Differential regulation of mast cell degranulation versus cytokine secretion by the actin regulatory proteins Coronin1a and Coronin1b. J Exp Med 208, 1777–1787 (2011). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mueller P. et al. Regulation of T cell survival through coronin-1-mediated generation of inositol-1,4,5-trisphosphate and calcium mobilization after T cell receptor triggering. Nat Immunol 9, 424–431 (2008). [DOI] [PubMed] [Google Scholar]
- de Hostos E. L., Bradtke B., Lottspeich F., Guggenheim R. & Gerisch G. Coronin, an actin binding protein of Dictyostelium discoideum localized to cell surface projections, has sequence similarities to G protein beta subunits. EMBO J 10, 4097–4104 (1991). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Takayanagi H. et al. Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev Cell 3, 889–901 (2002). [DOI] [PubMed] [Google Scholar]
- Kim H. et al. Selective inhibition of RANK blocks osteoclast maturation and function and prevents bone loss in mice. J Clin Invest 119, 813–825 (2009). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Saftig P. et al. Impaired osteoclastic bone resorption leads to osteopetrosis in cathepsin-K-deficient mice. Proc Natl Acad Sci USA 95, 13453–13458 (1998). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bossard M. J. et al. Proteolytic activity of human osteoclast cathepsin K. Expression, purification, activation, and substrate identification. J Biol Chem 271, 12517–12524 (1996). [DOI] [PubMed] [Google Scholar]
- Gelb B. D., Shi G. P., Chapman H. A. & Desnick R. J. Pycnodysostosis, a lysosomal disease caused by cathepsin K deficiency. Science 273, 1236–1238 (1996). [DOI] [PubMed] [Google Scholar]
- Asagiri M. et al. Cathepsin K-dependent toll-like receptor 9 signaling revealed in experimental arthritis. Science 319, 624–627 (2008). [DOI] [PubMed] [Google Scholar]
- Murray R. Z. & Stow J. L. Cytokine Secretion in Macrophages: SNAREs, Rabs, and Membrane Trafficking. Front Immunol 5, 538 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
- McQueney M. S. et al. Autocatalytic activation of human cathepsin K. J Biol Chem 272, 13955–13960 (1997). [DOI] [PubMed] [Google Scholar]
- Edwards J. R. & Mundy G. R. Advances in osteoclast biology: old findings and new insights from mouse models. Nat Rev Rheumatol 7, 235–243 (2011). [DOI] [PubMed] [Google Scholar]
- Wu H., Xu G. & Li Y.-P. Atp6v0d2 Is an Essential Component of the Osteoclast-Specific Proton Pump That Mediates Extracellular Acidification in Bone Resorption. Journal of Bone and Mineral Research 24, 871–885 (2009). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Baron R., Neff L., Louvard D. & Courtoy P. J. Cell-mediated extracellular acidification and bone resorption: evidence for a low pH in resorbing lacunae and localization of a 100-kD lysosomal membrane protein at the osteoclast ruffled border. J Cell Biol 101, 2210–2222 (1985). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Chen W. & Li Y. P. Generation of mouse osteoclastogenic cell lines immortalized with SV40 large T antigen. J Bone Miner Res 13, 1112–1123 (1998). [DOI] [PubMed] [Google Scholar]
- Li Y. P., Chen W., Liang Y., Li E. & Stashenko P. Atp6i-deficient mice exhibit severe osteopetrosis due to loss of osteoclast-mediated extracellular acidification. Nat Genet 23, 447–451 (1999). [DOI] [PubMed] [Google Scholar]
- Castro-Castro A. et al. Coronin 1A promotes a cytoskeletal-based feedback loop that facilitates Rac1 translocation and activation. EMBO J 30, 3913–3927 (2011). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ojeda V., Robles-Valero J., Barreira M. & Bustelo X. R. The disease-linked Glu-26-Lys mutant version of Coronin 1A exhibits pleiotropic and pathway-specific signaling defects. Mol Biol Cell 26, 2895–2912 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Blott E. J. & Griffiths G. M. Secretory lysosomes. Nat Rev Mol Cell Biol 3, 122–131 (2002). [DOI] [PubMed] [Google Scholar]
- Settembre C., Fraldi A., Medina D. L. & Ballabio A. Signals from the lysosome: a control centre for cellular clearance and energy metabolism. Nat Rev Mol Cell Biol 14, 283–296 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Jager S. et al. Role for Rab7 in maturation of late autophagic vacuoles. J Cell Sci 117, 4837–4848 (2004). [DOI] [PubMed] [Google Scholar]
- Gutierrez M. G., Munafo D. B., Beron W. & Colombo M. I. Rab7 is required for the normal progression of the autophagic pathway in mammalian cells. J Cell Sci 117, 2687–2697 (2004). [DOI] [PubMed] [Google Scholar]
- Cann G. M. et al. Developmental expression of LC3alpha and beta: absence of fibronectin or autophagy phenotype in LC3beta knockout mice. Dev Dyn 237, 187–195 (2008). [DOI] [PubMed] [Google Scholar]
- Tanida I., Ueno T. & Kominami E. LC3 conjugation system in mammalian autophagy. Int J Biochem Cell Biol 36, 2503–2518 (2004). [DOI] [PMC free article] [PubMed] [Google Scholar]
- He C. & Klionsky D. J. Regulation mechanisms and signaling pathways of autophagy. Annu Rev Genet 43, 67–93 (2009). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Otomo C., Metlagel Z., Takaesu G. & Otomo T. Structure of the human ATG12~ATG5 conjugate required for LC3 lipidation in autophagy. Nat Struct Mol Biol 20, 59–66 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Noda N. N. & Inagaki F. Mechanisms of Autophagy. Annu Rev Biophys 44, 101–122 (2015). [DOI] [PubMed] [Google Scholar]
- Galkin V. E. et al. Coronin-1A stabilizes F-actin by bridging adjacent actin protomers and stapling opposite strands of the actin filament. J Mol Biol 376, 607–613 (2008). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ferrari G., Langen H., Naito M. & Pieters J. A coat protein on phagosomes involved in the intracellular survival of mycobacteria. Cell 97, 435–447 (1999). [DOI] [PubMed] [Google Scholar]
- Jayachandran R. et al. RNA interference in J774 macrophages reveals a role for coronin 1 in mycobacterial trafficking but not in actin-dependent processes. Mol Biol Cell 19, 1241–1251 (2008). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Nishikawa K. et al. Blimp1-mediated repression of negative regulators is required for osteoclast differentiation. Proc Natl Acad Sci USA 107, 3117–3122 (2010). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kim K. et al. MafB negatively regulates RANKL-mediated osteoclast differentiation. Blood 109, 3253–3259 (2007). [DOI] [PubMed] [Google Scholar]
- Bosedasgupta S. & Pieters J. Inflammatory stimuli reprogram macrophage phagocytosis to macropinocytosis for the rapid elimination of pathogens. PLoS Pathog 10, e1003879 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
- BoseDasgupta S., Moes S., Jenoe P. & Pieters J. Cytokine-induced macropinocytosis in macrophages is regulated by 14-3-3zeta through its interaction with serine-phosphorylated coronin 1. FEBS J 282, 1167–1181 (2015). [DOI] [PubMed] [Google Scholar]
- Shinohara M. et al. Class IA phosphatidylinositol 3-kinase regulates osteoclastic bone resorption through protein kinase B-mediated vesicle transport. J Bone Miner Res 27, 2464–2475 (2012). [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.